Yibin Kang

47.6k total citations · 12 hit papers
193 papers, 25.3k citations indexed

About

Yibin Kang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yibin Kang has authored 193 papers receiving a total of 25.3k indexed citations (citations by other indexed papers that have themselves been cited), including 123 papers in Molecular Biology, 109 papers in Oncology and 54 papers in Cancer Research. Recurrent topics in Yibin Kang's work include Cancer Cells and Metastasis (56 papers), Bone health and treatments (25 papers) and TGF-β signaling in diseases (19 papers). Yibin Kang is often cited by papers focused on Cancer Cells and Metastasis (56 papers), Bone health and treatments (25 papers) and TGF-β signaling in diseases (19 papers). Yibin Kang collaborates with scholars based in United States, China and Germany. Yibin Kang's co-authors include Joan Massagué, Xin Lü, Manav Korpal, Guohong Hu, Klaus Pantel, Yong Wei, Wei Lu, Peter M. Siegel, Nilay S. Sethi and Theresa A. Guise and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Yibin Kang

189 papers receiving 25.0k citations

Hit Papers

A multigenic program medi... 2003 2026 2010 2018 2003 2008 2017 2004 2019 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A multigenic program mediating breast cancer metastasis to bone
    2003 2.0k citations Yibin Kang, Joan Massagué et al. profile →
  2. The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional Repressors ZEB1 and ZEB2
    2008 1.4k citations Guohong Hu, Yibin Kang et al. profile →
  3. Pre-metastatic niches: organ-specific homes for metastases
    2017 1.4k citations Yibin Kang et al. profile →
  4. Epithelial-Mesenchymal Transitions
    2004 1.2k citations Yibin Kang, Joan Massagué profile →
  5. Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis
    2019 727 citations Yibin Kang et al. profile →
  6. Tumor metastasis: moving new biological insights into the clinic
    2013 620 citations Liling Wan, Yibin Kang et al. profile →
  7. Hypoxia and Hypoxia-Inducible Factors: Master Regulators of Metastasis
    2010 556 citations Xin Lü, Yibin Kang profile →
  8. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors
    2005 522 citations Andy J. Minn, Yibin Kang et al. Journal of Clinical Investigation profile →
  9. Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization
    2011 508 citations Brian Ell, Andrés Blanco et al. profile →
  10. Context-dependent EMT programs in cancer metastasis
    2019 424 citations Nicole M. Aiello, Yibin Kang The Journal of Experimental Medicine profile →
  11. VCAM-1 Promotes Osteolytic Expansion of Indolent Bone Micrometastasis of Breast Cancer by Engaging α4β1-Positive Osteoclast Progenitors
    2011 397 citations Xin Lü, Yong Wei et al. profile →
  12. How important is EMT for cancer metastasis?
    2024 44 citations Toni Celià-Terrassa, Yibin Kang profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Yibin Kang 15.7k 11.2k 8.3k 2.7k 2.5k 193 25.3k
Gabriele Bergers 14.5k 0.9× 8.5k 0.8× 9.7k 1.2× 2.9k 1.1× 3.8k 1.5× 70 25.1k
Sendurai A. Mani 12.0k 0.8× 12.3k 1.1× 6.5k 0.8× 2.5k 0.9× 1.6k 0.6× 123 20.5k
Kenneth Aldape 13.1k 0.8× 6.6k 0.6× 8.1k 1.0× 4.8k 1.8× 3.3k 1.3× 369 27.8k
Ruggero De Maria 13.1k 0.8× 9.1k 0.8× 6.1k 0.7× 1.8k 0.7× 4.0k 1.6× 257 22.8k
Dennis C. Sgroi 11.1k 0.7× 8.7k 0.8× 6.8k 0.8× 2.8k 1.0× 2.2k 0.9× 173 21.0k
Ann F. Chambers 10.6k 0.7× 9.5k 0.8× 5.9k 0.7× 2.7k 1.0× 1.7k 0.7× 285 23.1k
Thomas Brabletz 15.3k 1.0× 10.2k 0.9× 7.5k 0.9× 2.0k 0.7× 2.0k 0.8× 174 23.0k
Jeremy N. Rich 20.6k 1.3× 14.1k 1.3× 12.0k 1.4× 4.0k 1.5× 3.9k 1.5× 314 38.3k
Eduard Batlle 11.7k 0.7× 9.4k 0.8× 3.7k 0.4× 1.6k 0.6× 2.8k 1.1× 87 19.8k

Countries citing papers authored by Yibin Kang

Since Specialization
Citations

This map shows the geographic impact of Yibin Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yibin Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yibin Kang more than expected).

Fields of papers citing papers by Yibin Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yibin Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yibin Kang. The network helps show where Yibin Kang may publish in the future.

Co-authorship network of co-authors of Yibin Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Yibin Kang. A scholar is included among the top collaborators of Yibin Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yibin Kang. Yibin Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Zheng, et al.. (2025). SMARCA4 Inhibits Breast Cancer Progression and Metastasis through RHOA Suppression. Cancer Research. 85(10). 1803–1818. 1 indexed citations
2.
Roichman, Asael, Gabriela Reyes‐Castellanos, Ziqing Chen, et al.. (2025). Dietary Fiber Lacks a Consistent Effect on Immune Checkpoint Blockade Efficacy Across Diverse Murine Tumor Models. Cancer Research. 85(17). 3335–3347. 2 indexed citations
3.
Lee, Eun-Mi, Yong Wei, Xiang Hang, et al.. (2025). CXCR4+ mammary gland macrophageal niche promotes tumor initiating cell activity and immune suppression during tumorigenesis. Nature Communications. 16(1). 4854–4854. 3 indexed citations
4.
Sarkar, Hirak, et al.. (2024). Deciphering normal and cancer stem cell niches by spatial transcriptomics: opportunities and challenges. Genes & Development. 39(1-2). 64–85. 6 indexed citations
5.
Kang, Yibin, et al.. (2024). Biomolecular condensates: A new lens on cancer biology. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1880(1). 189245–189245. 3 indexed citations
6.
Esposito, Mark, John K. Amory, & Yibin Kang. (2024). The pathogenic role of retinoid nuclear receptor signaling in cancer and metabolic syndromes. The Journal of Experimental Medicine. 221(9). 4 indexed citations
7.
Lu, Wen, Yong Tang, Clotilde Wiel, et al.. (2023). SOX9 drives KRAS-induced lung adenocarcinoma progression and suppresses anti-tumor immunity. Oncogene. 42(27). 2183–2194. 8 indexed citations
8.
Kumar, Sushil, Ajeya Nandi, Snahlata Singh, et al.. (2021). Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway. Nature Communications. 12(1). 432–432. 52 indexed citations
9.
Shen, Minhong, Heath A. Smith, Yong Wei, et al.. (2021). Pharmacological disruption of the MTDH–SND1 complex enhances tumor antigen presentation and synergizes with anti-PD-1 therapy in metastatic breast cancer. Nature Cancer. 3(1). 60–74. 45 indexed citations
10.
Ghergurovich, Jonathan M., Mark Esposito, Zihong Chen, et al.. (2020). Glucose-6-Phosphate Dehydrogenase Is Not Essential for K-Ras–Driven Tumor Growth or Metastasis. Cancer Research. 80(18). 3820–3829. 36 indexed citations
11.
Shen, Minhong, Shanshan Xie, Michelle Rowicki, et al.. (2020). Therapeutic Targeting of Metadherin Suppresses Colorectal and Lung Cancer Progression and Metastasis. Cancer Research. 81(4). 1014–1025. 37 indexed citations
12.
Pham, Kien, Do Luong Huynh, Daniel Delitto, et al.. (2020). E-cigarette promotes breast carcinoma progression and lung metastasis: Macrophage-tumor cells crosstalk and the role of CCL5 and VCAM-1. Cancer Letters. 491. 132–145. 33 indexed citations
13.
Esposito, Mark, Nandini Mondal, Todd M. Greco, et al.. (2019). Bone vascular niche E-selectin induces mesenchymal–epithelial transition and Wnt activation in cancer cells to promote bone metastasis. Nature Cell Biology. 21(5). 627–639. 179 indexed citations
14.
Celià-Terrassa, Toni, Daniel Dan Liu, Brian Ell, et al.. (2018). Hysteresis control of epithelial-mesenchymal transition dynamics conveys a distinct program with enhanced metastatic ability. Nature Communications. 9(1). 5005–5005. 123 indexed citations
15.
Chakrabarti, Rumela, Toni Celià-Terrassa, Sushil Kumar, et al.. (2018). Notch ligand Dll1 mediates cross-talk between mammary stem cells and the macrophageal niche. Science. 360(6396). 147 indexed citations
16.
Yang, Mu, Wei Bao, Xinmin Zhang, et al.. (2017). Short‐term and long‐term clinical outcomes of uncommon types of invasive breast cancer. Histopathology. 71(6). 874–886. 11 indexed citations
17.
Wan, Liling, Guohong Hu, Yong Wei, et al.. (2014). Genetic Ablation of Metadherin Inhibits Autochthonous Prostate Cancer Progression and Metastasis. Cancer Research. 74(18). 5336–5347. 35 indexed citations
18.
Lee, Shuet Theng, Min Feng, Yong Wei, et al.. (2013). Protein tyrosine phosphatase UBASH3B is overexpressed in triple-negative breast cancer and promotes invasion and metastasis. Proceedings of the National Academy of Sciences. 110(27). 11121–11126. 55 indexed citations
19.
Lü, Xin, Carol H. Yan, Min Yuan, et al.. (2010). In vivo Dynamics and Distinct Functions of Hypoxia in Primary Tumor Growth and Organotropic Metastasis of Breast Cancer. Cancer Research. 70(10). 3905–3914. 78 indexed citations
20.
Minn, Andy J., Yibin Kang, Inna Serganova, et al.. (2005). Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. Journal of Clinical Investigation. 115(1). 44–55. 522 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gabriele Bergers Breakdown of academic impact, for papers by Sendurai A. Mani Breakdown of academic impact, for papers by Kenneth Aldape Breakdown of academic impact, for papers by Ruggero De Maria Breakdown of academic impact, for papers by Dennis C. Sgroi Breakdown of academic impact, for papers by Ann F. Chambers Breakdown of academic impact, for papers by Thomas Brabletz Breakdown of academic impact, for papers by Jeremy N. Rich Breakdown of academic impact, for papers by Eduard Batlle
Rankless by CCL
2026